Euclid Advisors’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-15,150
Closed -$1.15M 514
2016
Q2
$1.15M Buy
+15,150
New +$1.11M 0.05% 320
2016
Q1
Sell
-188,367
Closed -$16.5M 519
2015
Q4
$16.5M Buy
+188,367
New +$16.1M 0.5% 61
2015
Q3
Sell
-32,860
Closed -$2.92M 470
2015
Q2
$2.92M Sell
32,860
-245,910
-88% -$21.5M 0.06% 282
2015
Q1
$24.2M Buy
+278,770
New +$23.4M 0.44% 53
2014
Q4
Sell
-399,260
Closed -$28.2M 534
2014
Q3
$28.2M Buy
399,260
+10,200
+3% +$727K 0.2% 112
2014
Q2
$27M Sell
389,060
-61,886
-14% -$4.36M 0.19% 126
2014
Q1
$33.9M Buy
450,946
+111,050
+33% +$8.32M 0.26% 87
2013
Q4
$23.9M Sell
339,896
-20,400
-6% -$1.33M 0.2% 113
2013
Q3
$22.3M Buy
360,296
+73,308
+26% +$4.74M 0.23% 102
2013
Q2
$17.7M Buy
+286,988
New +$17.3M 0.22% 114

Other funds holding ESRX

Euclid Advisors's ESRX Position: Q3 2016 in Review

Euclid Advisors sold out of Express Scripts Holding Company (ESRX) in Q3 2016, closing a stake of 15,150 shares — an estimated $1.15M sold.

Euclid Advisors first reported a position in ESRX in Q2 2013 and held it in 10 quarters. The position peaked at $33.9M in Q1 2014. 1,150 funds tracked by Wall St. Rank hold ESRX as of Q3 2016.

  • Euclid Advisors reported no remaining Express Scripts Holding Company position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 15,150 Express Scripts Holding Company shares in Q3 2016, an estimated $1.15M.
  • Euclid Advisors first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 10 quarters.
  • Euclid Advisors's Express Scripts Holding Company position peaked at $33.9M in Q1 2014.
  • 1,150 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.